Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 28, 2015; 21(12): 3671-3678
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3671
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3671
Table 6 Drugs used for endoscopic submucosal dissection
| DR group(n = 29) | PR group(n = 30) | P value | |
| Sedation duration (min) | 42.8 ± 26.7 | 37.6 ± 18.5 | 0.477 |
| Dexmedetomidine infusion rate (μg/kg per hour) | 0.5 ± 0.3 | ||
| Propofol infusion rate (μg/kg per minute) | 23.8 ± 16.5 | ||
| Remifentanil infusion rate (μg/kg per hour) | 5.7 ± 1.4 | 6.3 ± 4.0 | 0.451 |
| Additional propofol required | |||
| Patients | 8 (27.6) | 3 (10.0) | 0.083 |
| Dose (mg) | 16.9 ± 10.3 | 13.3 ± 5.8 | 0.596 |
| Butylscopolamine use | |||
| Patients | 4 (13.8) | 10 (33.3) | 0.078 |
| Dose (mg) | 3.4 ± 9.3 | 10.0 ± 16.4 | 0.066 |
- Citation: Kim N, Yoo YC, Lee SK, Kim H, Ju HM, Min KT. Comparison of the efficacy and safety of sedation between dexmedetomidine-remifentanil and propofol-remifentanil during endoscopic submucosal dissection. World J Gastroenterol 2015; 21(12): 3671-3678
- URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3671.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i12.3671